Tissue Microarray: A Rapidly Evolving Diagnostic and Research Tool

Overview

Journal Ann Saudi Med

Specialty General Medicine

Date 2009 Mar 26

PMID 19318744

Citations 48

Authors

Nazar M T Jawhar

Affiliations

Soon will be listed here.

Abstract

Tissue microarray is a recent innovation in the field of pathology. A microarray contains many small representative tissue samples from hundreds of different cases assembled on a single histologic slide, and therefore allows high throughput analysis of multiple specimens at the same time. Tissue microarrays are paraffin blocks produced by extracting cylindrical tissue cores from different paraffin donor blocks and re-embedding these into a single recipient (microarray) block at defined array coordinates. Using this technique, up to 1000 or more tissue samples can be arrayed into a single paraffin block. It can permit simultaneous analysis of molecular targets at the DNA, mRNA, and protein levels under identical, standardized conditions on a single glass slide, and also provide maximal preservation and use of limited and irreplaceable archival tissue samples. This versatile technique, in which data analysis is automated, facilitates retrospective and prospective human tissue studies. It is a practical and effective tool for high-throughput molecular analysis of tissues that is helping to identify new diagnostic and prognostic markers and targets in human cancers, and has a range of potential applications in basic research, prognostic oncology and drug discovery. This article summarizes the technical aspects of tissue microarray construction and sectioning, advantages, application, and limitations.

Citing Articles

Patient-derived xenograft models of gastrointestinal stromal tumors provide a ready-to-use platform for translational research.

Sutter L, De Cock L, Wang C, Gorgels D, Wyns K, Verbeeck K Dis Model Mech. 2025; 18(2).

PMID: 39853155 PMC: 11876840. DOI: 10.1242/dmm.052225.

Microarray integrated spatial transcriptomics (MIST) for affordable and robust digital pathology.

Juwayria , Shrivastava P, Yadav K, Das S, Mittal S, Kumar S NPJ Syst Biol Appl. 2024; 10(1):142.

PMID: 39616155 PMC: 11608264. DOI: 10.1038/s41540-024-00462-1.

Expression of Mutated Kinase in Canine Carcinomas-An Immunohistochemical Study.

Bartel A, Aupperle-Lellbach H, Kehl A, Weidle S, Aeschlimann L, Klopfleisch R Vet Sci. 2024; 11(11).

PMID: 39591358 PMC: 11598906. DOI: 10.3390/vetsci11110584.

Correlation between Periostin Expression and Pro-Angiogenic Factors in Non-Small-Cell Lung Carcinoma.

Wasik A, Podhorska-Okolow M, Dziegiel P, Piotrowska A, Kulus M, Kmiecik A Cells. 2024; 13(17.

PMID: 39272978 PMC: 11394527. DOI: 10.3390/cells13171406.

Single-cell transcriptome analysis upon ECM-remodeling meningioma cells.

Che W, Wang Y, Yang L, Wang H, Wang X, Lyu J Neurosurg Rev. 2024; 47(1):118.

PMID: 38491247 DOI: 10.1007/s10143-024-02349-5.

References

Fejzo M, Slamon D . Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. Am J Pathol. 2001; 159(5):1645-50. PMC: 1867064. DOI: 10.1016/S0002-9440(10)63011-8. View

Mousses S, Kallioniemi A, Kauraniemi P, Elkahloun A, Kallioniemi O . Clinical and functional target validation using tissue and cell microarrays. Curr Opin Chem Biol. 2002; 6(1):97-101. DOI: 10.1016/s1367-5931(01)00283-6. View

Rhodes A, Jasani B, Couturier J, McKinley M, Morgan J, Dodson A . A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer. Am J Clin Pathol. 2002; 117(1):81-9. DOI: 10.1309/4NCM-QJ9W-QM0J-6QJE. View

Alkushi A, Clarke B, Akbari M, Makretsov N, Lim P, Miller D . Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data. Mod Pathol. 2007; 20(11):1156-65. DOI: 10.1038/modpathol.3800950. View

Watanabe A, Cornelison R, Hostetter G . Tissue microarrays: applications in genomic research. Expert Rev Mol Diagn. 2005; 5(2):171-81. DOI: 10.1586/14737159.5.2.171. View

Sharangpani G, Joshi A, Porter K, Deshpande A, Keyhani S, Naik G . Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer. J Microsc. 2007; 226(Pt 3):244-55. DOI: 10.1111/j.1365-2818.2007.01772.x. View

Rimm D, Camp R, Charette L, Olsen D, Provost E . Amplification of tissue by construction of tissue microarrays. Exp Mol Pathol. 2001; 70(3):255-64. DOI: 10.1006/exmp.2001.2363. View

Giltnane J, Rimm D . Technology insight: Identification of biomarkers with tissue microarray technology. Nat Clin Pract Oncol. 2005; 1(2):104-11. DOI: 10.1038/ncponc0046. View

Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A . Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res. 1999; 5(8):1966-75. View

10.

Rhodes D, Sanda M, Otte A, Chinnaiyan A, Rubin M . Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J Natl Cancer Inst. 2003; 95(9):661-8. DOI: 10.1093/jnci/95.9.661. View

11.

Parker R, Huntsman D, Lesack D, Cupples J, Grant D, Akbari M . Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. Am J Clin Pathol. 2002; 117(5):723-8. DOI: 10.1309/PEF8-GL6F-YWMC-AG56. View

12.

Hsu F, Nielsen T, Alkushi A, Dupuis B, Huntsman D, Liu C . Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol. 2002; 15(12):1374-80. DOI: 10.1097/01.MP.0000039571.02827.CE. View

13.

Kumar B, De Silva M, Venter D, Armes J . Tissue microarrays: a practical guide. Pathology. 2004; 36(4):295-300. DOI: 10.1080/00313020410001721555. View

14.

Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T . High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol. 1999; 154(4):981-6. PMC: 1866554. DOI: 10.1016/S0002-9440(10)65349-7. View

15.

Zhang J . Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma. Autoimmun Rev. 2007; 6(3):143-8. PMC: 2740754. DOI: 10.1016/j.autrev.2006.09.009. View

16.

Williamson M, Masters J . 21st century molecular biology in urology. BJU Int. 2001; 88(5):451-7. DOI: 10.1046/j.1464-4096.2001.02378.x. View

17.

Wang H, Wang H, Zhang W, Fuller G . Tissue microarrays: applications in neuropathology research, diagnosis, and education. Brain Pathol. 2002; 12(1):95-107. PMC: 8095954. DOI: 10.1111/j.1750-3639.2002.tb00426.x. View

18.

Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S . Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998; 4(7):844-7. DOI: 10.1038/nm0798-844. View

19.

Matysiak B, Brodzeller T, Buck S, French A, Counts C, Boorsma B . Simple, inexpensive method for automating tissue microarray production provides enhanced microarray reproducibility. Appl Immunohistochem Mol Morphol. 2003; 11(3):269-73. DOI: 10.1097/00129039-200309000-00011. View

20.

Kallioniemi O, Wagner U, Kononen J, Sauter G . Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet. 2001; 10(7):657-62. DOI: 10.1093/hmg/10.7.657. View